Give your patients dry eye relief with SYSTANE®1,2
The #1 Selling Dry Eye Drops Brand in Canada3
Dry eye disease is on the rise due to a range of causes.4,5
Help your patients find real relief with SYSTANE® COMPLETE Preservative-Free.1
Aging
Population
Pollution
Digital Device
Usage
Why SYSTANE®?
As the #1 doctor and pharmacist recommended brand of artificial tears,12 SYSTANE® offers a range of formulas that provides real, long-lasting relief for dry eye symptoms.1,2
References:
1.Silverstein S, Yeu E, Tauber J, et al. Symptom Relief Following a Single Dose of Propylene Glycol-Hydroxypropyl Guar Nanoemulsion in Patients with Dry Eye Disease: A Phase IV, Multicenter Trial. Clin Ophthalmol. 2020;14:3167-3177.
2. Rangarajan R, Kraybill B, Ogundele A, Ketelson H. Effects of a Hyaluronic Acid/Hydroxypropyl Guar Artificial Tear Solution on Protection, Recovery, and Lubricity in Models of Corneal Epithelium. J Ocul Pharmacol Ther. 2015;31(8):491-497.
3. Alcon data on file, 2023.
4. MarketScope LLC. 2020 Dry Eye Products Report: A Global Market Analysis for 2019 to 2025. St. Louis, MO: MarketScope LLC; 2020.
5. Farrand KF, Fridman M, Stillman IÖ, Schaumberg DA. Prevalence of Diagnosed Dry Eye Disease in the United States Among Adults Aged 18 Years and Older. Am J Ophthalmol. 2017;182:90-98.
6. Yeu E, et al. Efficacy and Safety of Phospholipid Nanoemulsion-Based Ocular Lubricant for the Management of Various Subtypes of Dry Eye Disease: A Phase IV, Multicenter Trial. Clin Ophthalmol. 2020;14:2561-2570.
7. Bickle, K., Miller, J.R., Tauber, J. et al. Multi-symptom Relief with Propylene Glycol-Hydroxypropyl-Guar Nanoemulsion Lubricant Eye Drops in Subjects with Dry Eye Disease: A Post-Marketing Prospective Study. Ophthalmol Ther. 2024;(13):481–494.
8. Alcon data on file, 2023.
9. Alcon data on file, 2023.
10. Pucker AD, et al. Evaluation of Systane Complete for the Treatment of Contact Lens Discomfort. Cont Lens Anterior Eye. 2020;43:441-447.
11. Carlson E, et al. Impact of Hyaluronic Acid-Containing Artificial Tear Products on Reepithelialization in an In Vivo Corneal Wound Model. J Ocul Pharmacol Ther. 2018;34(4):360-364.
12. Alcon data on file, 2023.
Important safety information
Click here for Product Information